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A Novel Graphene Quantum Dot-Based mRNA Delivery
Platform
Ya Liu+,[a, b] Changhong Zhao+,[a, f] Alan Sabirsh+,[c] Lilei Ye,[d] Xiaoqiu Wu,*[c] Hongbin Lu,*[b]
and Johan Liu*[a, e]
Abstract: During the last decades, there has been growing
interest in using therapeutic messager RNA (mRNA) together
with drug delivery systems. Naked, unformulated mRNA is,
however, unable to cross the cell membrane and is susceptible
to degradation. Here we use graphene quantum dots (GQDs)
functionalized with polyethyleneimine (PEI) as a novel mRNA
delivery system. Our results show that these modified GQDs can
be used to deliver intact and functional mRNA to Huh-7
hepatocarcinoma cells at low doses and, that the GQDs are not
toxic, although cellular toxicity is a problem for these first-
generation modified particles. Functionalized GQDs represent a
potentially interesting delivery system that is easy to manufac-
ture, stable and effective.
1. Introduction
In recent years, graphene quantum dots (GQDs) have emerged
as an attractive platform for bio-applications, involving biosens-
ing, biomedical imaging and drug delivery. This is because
various desirable attributes from GQDs: dispersibility, good
biocompatibility, large surface area, colloidal stability, and
tunable surface structure. Moreover, GQDs are able to respond
to physical stimuli, such as magnetic fields, ultrasound[3] and
light. These unique responding features allow the accurate
control of drug release.[1a] To date, some exciting examples,
include a graphene oxide/carbon/mesoporous silica photo-
responsive drug delivery platform, an electrical fields activated
graphene based microcapsule platform, and graphene based
photothermal therapy[7] have been reported. Notably, GQDs are
able to selectively interact with DNA or RNA and protect them
from enzymatic degradation,[1b] suggests the possibility of
integrating GQDs with DNA or RNA-based therapeutics.
Messenger RNA (mRNA)-based therapeutics are a promising
class of drugs with a range of advantages, including reduced
genotoxicity, increased control of product (protein) formation,
no need for nuclear localization or transcription and better
compatibility with biological systems. Structurally, mRNA is a
single-strand poly nucleotide that in cells is transcribed from a
DNA template prior to translation into protein. mRNA molecules
are, however, large, carrying a net charge and unstable in most
biological fluids. These poor cell penetration and instability
characteristics limit their use as therapeutic agents. To cope
with this issue, composite particles made from mRNA and GQDs
would ameliorate many of these problems due to the surface
properties and colloidal stability of GQDs.[1b]
Unmodified GQDs will not, however, bind mRNA very well
so GQDs need to be functionalized. In this regard, Polyethyle-
neimine (PEI) possess a high cationic charge density and allows
the complexation of RNA and DNA. Besides, PEI functionalized
carbon nanotubes (CNTs) have been designed successfully for
nucleic acid delivery. Given the similar surface properties of
GQDs and CNTs, we hypothesized that PEI would be a good
starting point for exploring the utility of GQDs as an mRNA
delivery system.
In this work, GQDs were prepared from citric acid, and
surface zeta potential of GQDs were tailored by PEI. The GQDs/
mRNA complexes were prepared by combining the functional-
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ized GQDs (FGQDs) with mRNA. The mRNA molecules bind to
the particles as a result of simple charge interactions. Finally,
the novel FGQDs were used to deliver intact and functional
mRNA to Huh-7 hepatocarcinoma (liver) cells. This cell line is
used as a model for the liver because most nanomedicine
particles are cleared by the liver, resulting in higher levels of
transfection in this organ.
2. Results and Discussion
GQDs were prepared from citric acid, as shown in Figure 1. After
pyrolysis and carbonization, the carbon atoms grow to form
interlinked hexagonal carbon rings (at the red ring site), and
thus creating graphene. After that, PEI was used to functionalize
the surface of the GQDs following a reaction with graphene
carboxyl groups. The high concentration of positively charged
amino groups on PEI imparts a surface zeta potential that
permits mRNA complexation.
FTIR was used to characterize the GQDs and PEI-GQDs. After
pyrolysis, only peaks at 620, 1646, 2103 cm  1 are observed on
the FTIR spectrum of GQDs, corresponding to C  O  C, C=O and
C=C=O groups, as shown in Figure 2(a), indicating the success-
ful preparation of GQDs. Additionally, the GQDs spectra do not
reveal any absorption caused by C  H bonds, suggesting the
complete carbonization of citric acid. After PEI functionalization,
typical peaks of C  N and N  H are observed in the FTIR
spectrum of FGQDs at 1550 and 1396 cm  1, see Figure 2(b).
Compared with the absorption peak of PEI, the position of C  N
and N  H absorption peaks tend to shift to lower wavenumber.
Such a blue shift phenomenon suggests a decrease in the
polarity of these two bonds and can be attributed to the
formation of the C  N bond between GQDs and PEI.
As shown in Figure 3(a), the average size of GQDs is 2–5 nm
with a thickness less than 1 nm, indicating the GQDs were
composed of 1–3 layers of graphene sheets. After functionaliza-
tion with PEI, FGQDs grows to tens of nanometers. While FGQDs
consist of 1–6 layers of graphene sheets with a thickness of
0.33–2 nm. Such results keep consistent with the TEM images of
GQDs, see Figure S1. The surface zeta potential of GQDs is
Figure 1. A schematic overview of the FGQDs synthesis. The red ring and arrow show the carbonization reaction sites.
Figure 2. (a) FTIR spectrums of GQDs and citric acid; (b) FTIR spectrums of
PEI, FGQDs and GQDs.
Figure 3. Atomic force microscopy images of (a) GQDs and (b) FGQDs. Insets
show image intensities along the indicated lines. Panels (c) and (d) show the
surface charge of the GQDs before and after PEI functionalization
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  36 V due to the oxygen-containing functional groups, includ-
ing hydroxyl and carboxyl groups. Following PEI functionaliza-
tion, the surface zeta potential of FGQDs increases to + 24.2 V.
This increase is a result of the positively charged amino groups
on PEI. Notably, the surface zeta potential of prepared FGQDs
exhibits pH stability, as shown in Figure S2. The surface zeta
potential of FGQDs stays at around + 22 V over a pH range of
4–14. This positively charged surface enables the GQDs to
combine with mRNA. Additionally, UV absorption and
fluorescence properties of GQDs and FGQDs were investigated
in Figure S3. Both GQDs and FGQDs are able to absorb UV light
at 360 nm and emit blue fluorescence.
The FGQDs have a positively charged surface, so an electro-
statically driven interaction would be expected between FGQDs,
and negatively charged EEGFP mRNA. FGQDs to mRNA ratios
were expressed as molar ratios of N in FGQDs to molar ratios of
P in mRNA (N/P ratio). As shown in Figure 4, agarose gel
electrophoresis confirmed the formation of a complex between
FGQDs and mRNA at various N/P ratios (i. e. at N/P 2, 4, 6, 8, 10,
20, 40 60, 100). At all N/P ratios, mRNA completely complexed
with FGQDs, and remained close to the loading position. The
particle size of the FGQDs/mRNA complexes formed at various
N/P ratios demonstrate that higher N/P ratios lead to smaller
particle sizes as a result of reduced amounts of positively
charged FGQDs being available at lower N/P ratios (Figure 5(a)).
All the FGQDs/mRNA complexes have particle sizes below
300 nm.
2.1. Delivery of Functional mRNA to Cell Cultures
mRNA-based therapeutics offer new possibilities for treating
disease, so a variety of different biomaterial-based systems have
been developed for mRNA delivery, such as lipid
nanoparticles,[10] polymeric nanoparticles,[11] and gold
nanoparticles.[12] However, it is still necessary to find novel
biomaterial delivery systems that can stably, safely and
effectively deliver mRNA to specific sites with high selectivity
and efficient protein expression. Here, FGQDs were employed
to deliver mRNA, and the transfection efficiency was evaluated
both qualitatively and, quantitatively by calculating the % EGFP
positive cells in the images obtained using high-throughput
microscopy.
Our investigation of FGQDs/mRNA complexes began with
experiments to determine the optimum ratio between FGQDs
and the mRNA cargo. We created particles using various ratios,
and DLS measurements indicated that particle size increased
following mRNA addition and, that as expected, particle size
decreased if mRNA condensation was then encouraged by
adding more FGQDs and thus more charge (Figure 5(a)). Note
that unbound mRNA (N/P 0) assumes a spherical form in
aqueous buffers. The functional cellular experiments were
performed at relatively low doses and exposures were short
because of the acidic nature of this first round of formulations.
Decreased eGFP production at higher doses of the FGQDs/
mRNA complexes (Figure 5(b)) is the result of media acidity,
rather than FGQDs toxicity. A clear relationship was seen where
an increasing proportion of FGQDs was less effective (Fig-
ure 5(c)). Encouraged by this, and the fact that protein
production was seen at very low doses, we continued with a
second round of functional experiments with an improved
formulation that was much less acidic.
Both the reference lipid nanoparticle (Figure 6(a) and (c))
and the FGQDs ((b) and (d)) could deliver functional EGFP
mRNA to Huh-7 cells. Qualitatively, differences are apparent.
Wells treated with FGQDs tended to have fewer cells expressing
EGFP, but positive cells did produce a lot of protein. This is in
contrast to the more uniform expression obtained followingFigure 4. eGFP mRNA gel electrophoresis is retarded following complexation
with FGQDs at various charge (N/P) ratios (0–100).
Figure 5. Particle size and function at various FGQDs to mRNA ratios. (a) As the proportion of FGQDs increases in relation to the number of mRNA molecules
in a solution, increased mRNA condensation results in smaller particle sizes. (b) A 2 h pulse of particles was created by removing dosed particles after 2 h and
adding fresh growth medium. Imaging and quantification occurred at 24 h. Low doses of FGQDs/mRNA complexes resulted in particle uptake and dose-
dependent eGFP expression. (c) The amount of eGFP protein produced, shown as the total area under the curve for all particle doses together, was inversely
proportional to the N/P ratio, with lower ratios resulting in more protein production. n = 3 for all data points. 24 h continuous dosing produced similar data
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Figure 6. Functional cellular data obtained following transfection. Shown are representative images, of Huh-7 cells exposed to LNPs (a and c) FGQDs (b and d)
and control cells dosed with buffer (e), taken 24 h following the start of a 2 h pulsed exposure to either LNPs or FGQDs complexed with mRNA encoding for
eEGFP (the entire 2 h data set is shown in f and h below). FGQDs images are taken from wells that produced the most EGFP: an N/P ratio of 1 at 3333 ng/mL
mRNA (b) and an N/P ratio of 2 at 213 ng/mL mRNA (d). The corresponding points on the curves in panel f are noted with circle * and diamond ♦ symbols.
Images from wells receiving LNPs at the same doses and time points are shown in a and c. EGFP protein production is shown in magenta, propidium iodide
staining in yellow and nuclear staining with Hoechst 33342 is shown in blue; scale bars show 100 μm. Qualitatively similar images were obtained following
24 h of continuous exposure but with more PI signal (intensity and % positive cells). Quantitative image analysis data is shown in panels f and g for eEGFP
(protein production) and h and i for PI staining (cell viability). The left panels (f and h) show data obtained at 24 h following a 2 h pulsed dose, while the right
panels (g and i) show data obtained following continuous 24 h exposure. Curves show responses to FGQDs or reference LNPs complexed with mRNA at
different charge ratios (N/P ratios). Data is shown as mean�SEM from 6 wells for each point (combined data from 3 replicates in two separate experiments
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LNP transfection. Likewise, FGQDs-treated wells did have more
propidium iodide staining than the reference lipid-based
particles, indicating greater disruption of the plasma mem-
brane, a likely side-effect of the PEI functionalization, rather
than the graphene itself.
GQDs are reported to be biocompatible and have great
promise for drug delivery,[13] however, the size, functionalization
of GQDs can influence their cytotoxicity in different ways.[14] To
facilitate cellular uptake, nanoparticles are often designed to be
catatonically charged, which can enhance the interaction of the
particles with the anionic cell membrane, however, this results
in cytotoxic effects as well.[15] The optimal doses and formula-
tions, if one considers the ratio between EGFP production and
cellular toxicity, occur at relatively low doses for FGQDs: 213 ng/
mL mRNA is optimal for an N/P ratio of 2, using either PBS or
Tris as a buffer system, and a 2 h pulsed dose (Figure 6(f) and
(h)). Longer, 24 h exposures increase cellular toxicity, resulting
in lower protein expression (Figure 6(g) and (i)). The cell health
data in Figure S4 shows similar results. Interestingly, an N/P
ratio of 1 between the FGQDs and the mRNA cargo resulted in
less potent, but also less toxic particles, and in this case, the
optimal dose was more than a magnitude higher.
The FGQDs tested here were both less effective and more
toxic than the reference LNP-based mRNA delivery system, but
this was not unexpected as these are the first generation of
functionalized graphene-based delivery systems we have
developed, while the LNPs represent a more mature technol-
ogy. Furthermore, because the toxicity is primarily a result of
functionalization[16] and the resulting particle charge, alternative
functionalization strategies have the potential to produce less
toxic particles. Hybrid particles, consisting of GQDs in complex
with lipids, are an interesting possibility. GQDs do, however,
have other desirable properties as well including a large surface
area and the ability to respond to external stimuli such as
ultrasound, magnetic fields and light. Since LNPs are sensitive
to shearing force during formulation (AstraZeneca unpublished
data), a shear tolerance test was performed on the FGQDs/
mRNA complex formed at N/P 2. The sample was pressed
through a thin needle (27G) 20 times. The performance of the
FGQDs/mRNA complex was not very sensitive to this treatment
and retained substantial activity, Figure 6(f–i). Finally, we found
that one freeze-thaw cycle did have an effect on the potency of
the complexes but did not reduce cellular toxicity.
3. Conclusion
In this work, we prepared a novel mRNA delivery platform
based on GQDs. Covalent functionalization of the GQDs surface
with PEI was used to achieve positively charged GQDs (termed
functionalized GQDs or FGQDs). Our results show that FGQDs
were able to successfully complex mRNA and deliver it intact to
the cytoplasm of Huh-7 hepatocarcinoma cells. Furthermore,
unlike LNP, the FGQDs/mRNA complex is not very sensitive to
shearing force. The transfection efficiency for FGQDs/mRNA
complexes was as high as 25 % with a formulation concen-
tration of 4000 ng mRNA/mL, but comparable transfection
efficiencies could be achieved at much lower doses if the ratio
between the carrier and the cargo was optimized. This work
describes the first steps towards a potentially interesting
preparation method for stable and effective mRNA delivery
systems based on GQDs.
Experimental Section
Materials
50 wt % polyethylenimine (PEI, Mw 60,000 by GPC) solution and
citric acid were purchased from Sigma-Aldrich Co. Ltd, Sweden.
EEGFP mRNA (5moU) was purchased from Trilink BioTechnologies,
Inc., USA. The huh-7 hepatocarcinoma cell line was obtained from
AstraZeneca AB, Sweden and originally sourced from ATCC. pH test
paper was purchased from Fisher Scientific Co. Ltd, Sweden. The
chemicals were analytically pure and used as received.
Preparation of GQDs
GQDs were prepared using a typical bottom-up method. Briefly, 1 g
citric acid was dissolved in 80 mL distilled water while stirring for
30 min at room temperature. Then, the prepared transparent
solution was transferred in a 150 mL Teflon-lined stainless-steel
autoclave. After that, the autoclave was put into a muffle furnace at
200 °C for 6 h. The resulting orange liquid was used to prepare
GQDs by adding it drop by drop into 100 mL of 10 mg /mL NaOH
solution, under vigorous stirring. After adjusting the pH to 7.0, an
aqueous solution of GQDs was obtained. This solution was filtered
and dialyzed (3.5 kDa cut-off) for 7 days under running water. After
concentrating the solution using centrifugation (8000 r/min), an
orange solution of GQDs (4 mg/mL) was obtained. The production
yield was calculated to be about 56 %.
Preparation of Functionalized GQDs (FGQDs)
PEI was used to modify the surface zeta potential of pre-prepared
GQDs. GQDs were aminated by adding ethylenediamine (EDA) and
dicyclohexycarbodiimide (DCC) in 100 mL GQDs solution stirred for
1 h at 80 °C. After that, 10 wt % PEI solution was added into the
aminated GQDs solution with stirring for 8 h. The resulting solution
was further purified using 3.5 K MWCO dialysis tubing for 7 days
under running water, resulting in a final concentration of 2.8 mg/
mL FGQDs. FGQDs fluoresce somewhat with emission in the green
part of the spectrum (around 520 nm), This could be mitigated by
using moderate concentrations as the fluorescence at the concen-
trations used here is not intense when compared with eEGFP.
Formation of FGQDs/mRNA Complex
FGQDs to mRNA ratios were expressed as molar ratios of N in
FGQDs to molar ratios of P in mRNA (N/P ratio). FGQDs/mRNA
complex was formed by mixing varied volumes of FGQDs and
mRNA solution to achieve the desired N/P ratio in water or adjusted
to pH 7.5 using 1 M Tris pH 8 and incubated for 1 h at RT before
analysis. The obtained FGQDs/mRNA complexes were examined by
agarose gel electrophoresis (1 % Agarose E-GelEX, Invitrogen). The
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Cell Transfer Efficiency and Cytotoxicity Test
Huh-7 hepatocarcinoma cells were cultured in DMEM supple-
mented with 10 % fetal bovine serum, 5 % L-glutamine, 5 % sodium
pyruvate and incubated at 37 °C in 5 % CO2. Cells were seeded into
384 well Perkin Elmer Cell Carrier imaging plates two days prior to
test. FGQDs/mRNA source plates were created using acoustic
dispensing (Echo 655) followed by robotic transfer (Agilent Bravo)
to the Huh-7 cultures. LNPs and FGQDs were incubated together
with the growth medium normally used to maintain the cells, and
the cells were incubated with FGQDs/mRNA in 2 different ways:
24 h continuous incubation or, using a 2 h pulse incubation
followed by removal of the FGQDs/mRNA and an additional 22 h
incubation in fresh growth medium. MC3-based lipid nanoparticles
(LNP) were added and used as a control. Hoechst 33342 and
propidium iodide were added directly to living cells 24 h to stain
nuclei and cells with compromised membranes respectively.
Confocal images were acquired using a 20 × objective (Olympus, NA
0.95) at two points in every well (Yokogawa CV7000). Wells were
dosed in triplicate and the experiment was run twice.
Particles Characterisation
Fourier-transform infrared (FTIR) and Raman spectroscopy were
used to characterize the chemical structure of GQDs and FGQDs.
The value of zeta potentials was measured using a Malvern
zetasizer (Malvern Panalytical, England). Atomic force microscopy
(AFM) was used to analyse the morphology of GQDs and FGQDs in
tapping mode on a Nanoscope IIIa (Digital Instruments) with NSC15
tips (silicon cantilever, MikroMasch). High resolution transmission
electron microscopy (HRTEM) observations were made on a Tecnai
G2 F20S-TWIN 200KV electron microscope. UV-Vis absorption was
characterized using a UV/Vis/NIR spectrophotometer (Agilent Cary
60). All FL spectra were obtained by an FL spectrophotometer (Cary
Eclipse, Varian). pH values were obtained using pH test paper.
Data Analysis
The eEGFP mRNA transgene expression was investigated using
confocal imaging after 24 h of incubation with FGQDs/mRNA. For
transfection of mRNA and cytotoxicity test, 8 doses were used per
formulation (as shown in Table S1), 3 replicates were performed per
dose and two fields of view were acquired in each well. Columbus
(ver2.9; Perkin Elmer) was used for automated analysis of the
images. 15000 cells/concentration were typically analysed, and
initial analysis extracted 16 parameters/cell. Cells were classified as
EGFP-positive, PI-positive (dead), and/or PI-negative (living). Addi-
tional measurements related to cell health were also generated
(cell counts, nuclear intensities and nuclear morphological meas-
ures).
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FULL PAPERS
Message delivered! A novel
graphene quantum dots based
mRNA drug delivery platform was
prepared. The results show that
these modified GQDs can deliver
intact and functional mRNA to Huh-7
hepatocarcinoma cells at low doses.
The transfection efficiency for
FGQDs/mRNA complexes was 25 %
with a formulation concentration of
4000 ng mRNA/mL, but comparable
transfection efficiencies could be
achieved at much lower doses if the
ratio between carrier and cargo was
optimized. This work describes the
first steps towards a potentially inter-
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